Muscleblind-like 1 Antibody (3E7)

This product is produced by and distributed for Abnova, a company based in Taiwan.

Several important human diseases are associated with expansion of polynucleotide sequences, in most cases trinucleotide repeats. Myotonic dystrophy (DM1) is one of these diseases, and is associated with increases in the number of CTG repeats in the UTR of the gene encoding myotonin (a.k.a. DM Kinase, DMK or myotonin-Protein Kinase), a ser/thr kinase expressed specifically in muscle. Mammalian genomes contain three muscleblind-like proteins, generally referred to as MBNL1, MBNL2 and MBNL3, and all three were found to associate with long double stranded CUG RNA repeats, thus, being triplet repeat expansion dsRNA-binding proteins.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Showing Publications 1 - 3 of 3.

Publications using H00004154-M02	Applications	Species
Yadava R, Kim Y, Mandal M et al. MBNL1 overexpression is not sufficient to rescue the phenotypes in a mouse model of RNA toxicity. Hum Mol Genet. 2019-07-15 [PMID: 30997488]
Ravel-Chapuis A, Al-Rewashdy A, Belanger G et al. Pharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse muscles. Hum Mol Genet 2018-08-08 [PMID: 29982462]
Rehman S, Gladman JT, Periasamy A et al. Development of an AP-FRET Based Analysis for Characterizing RNA-Protein Interactions in Myotonic Dystrophy (DM1). PLoS One. 2014-04-29 [PMID: 24781112]

Array H00004154-M02

• Muscleblind-like 1 Antibodies
• Muscleblind-like 1 Lysates
• Muscleblind-like 1 Proteins